Answers are grounded in this paper and cite their sources.
Background Yi-Nao-Kang (YNK), a traditional Chinese medicine formula widely used for ischemic stroke rehabilitation, is supported by long-term clinical experience, yet the evidence for its efficacy remains limited and its neurovascular protective mechanisms are undefined, prompting this mechanistic investigation. Materials and methods We examined the mechanism by which YNK protects against cerebral ischemia–reperfusion injury (CIRI), using an in vivo middle cerebral artery occlusion (MCAO) model in SD rats and an in vitro oxygen–glucose deprivation/reoxygenation (OGD/R) model in bEnd.3 cells. The effects of YNK on the PERK/eIF2α/QRICH1 pathway were verified by Western blotting, quantitative real time PCR (qPCR), immunofluorescence staining, biochemical analysis of oxidative stress markers and detection of inflammatory cytokines. Results Compared with the MCAO model group, YNK administration reduced cerebral infarct volume, improved neurological deficits, and was accompanied by reduced endoplasmic reticulum stress (ERS), downregulated endothelial and pericyte QRICH1 expression, and mitigated oxidative stress and neuronal apoptosis; in OGD/R-exposed bEnd.3 cells, the PERK inhibitor GSK2656157 produced protective and pathway-suppressing effects similar to those of YNK. Conclusion YNK ameliorates cerebral ischemia-reperfusion injury, and its protective effects are accompanied by suppression of PERK/eIF2α/QRICH1-mediated ERS in brain microvascular endothelial cells. Because active constituents were not identified and YNK-only control groups were not included, these findings should be considered preliminary and hypothesis-generating; further preclinical evaluation is required before clinical translation.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: